The Future of Engineered Tissue
"Frontier Bio is doing more than just creating lab-grown human tissues. They're paving the way for a future where organ donors are no longer needed, and animal testing is a thing of the past."
George Church
​​
Scientific Advisor
TOWARDS ON-DEMAND HUMAN TISSUES
Only 10% of Global Organ Demand is Met
According to the World Health Organization
>150,000 Organ Transplants Per Year
Lifetime costs for an organ transplant can exceed $1M
Starting at the foundation: blood vessels
Engineering a new organ is impossible without its vascular system... blood vessels are the key. We are creating tissue-engineered blood vessels for use as vascular grafts to treat cardiovascular disease and trauma.
Cardiovascular disease is the #1 cause of death worldwide
Synthetic Vessels Fail Too Often
The $2B synthetic vascular graft market is plagued by high failure rates, while vessel-harvesting is invasive, limited, and adds hours to critical surgeries.
Our Solution: A Living Vascular Graft
Our solution is a bioresorbable scaffold seeded at the bedside with the patient's own stem cells. The body remodels this "living graft" into a new, natural blood vessel, eliminating immune rejection and long manufacturing delays.
ESTABLISHING OURSELVES AS A LEADER IN TISSUE ENGINEERING
To build the future, we first had to master the present. We have successfully commercialized our human-based tissue models & tissue engineering services.
A More Relevant, Cruelty-Free Solution
Lab-grown human tissues provide more relevant insights and are a cruelty-free alternative compared to animal testing.
The New Era in Preclinical Testing
The FDA and NIH have just taken major steps to move beyond animal testing, transforming how new therapies are developed.
Read the latest announcements:
Frontier Bio is Built for This Moment
Our human-based tissue models & services provide a critical alternative to animal testing. The success of this platform directly accelerates our long-term vision.
The future is here, Don’t miss it
Supported By
